QIAGEN NV (QGEN)

38.30
0.23 0.60
NYSE
Prev Close 38.53
Open 38.54
Day Low/High 37.97 / 38.69
52 Wk Low/High 31.10 / 39.45
Volume 1.76M
Exchange NYSE
Shares Outstanding 225.51B
Market Cap 8.96B
Div & Yield N.A. (N.A)
QIAGEN N.V. To Report First Quarter 2019 Results

QIAGEN N.V. To Report First Quarter 2019 Results

QIAGEN N.V.

QIAGEN Launches QCI Interpret Bioinformatics Features For Use For Blood Cancers As Well As A Novel Myeloid Gene Panel For GeneReader NGS System

QIAGEN Launches QCI Interpret Bioinformatics Features For Use For Blood Cancers As Well As A Novel Myeloid Gene Panel For GeneReader NGS System

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of two novel products to deliver actionable insights on a wide range of blood cancers: a new workflow for the QIAGEN Clinical Insight (QCI) Interpret bioinformatics solution for...

TheStreet Quant Rating: A- (Buy)